This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Modernatx, Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Michael Watson: Innovator in mRNA Vaccine Technology
Introduction
Michael Watson is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of vaccine development, particularly in the area of mRNA technology. His innovative work has the potential to impact public health positively.
Latest Patents
Michael Watson holds a patent for an HMPV/hPIV3 mRNA vaccine composition. This patent describes a vaccine composition that includes a chemically-modified messenger ribonucleic acid (mRNA) encoding a hMPV fusion (F) glycoprotein and a chemically-modified mRNA encoding a hPIV3 F glycoprotein. The formulation is designed in a cationic lipid nanoparticle formulation, which is crucial for inducing an antigen-specific immune response.
Career Highlights
Watson is currently associated with ModernaTX, Inc., a leading biotechnology company known for its pioneering work in mRNA technology. His role at the company allows him to contribute to groundbreaking research and development in the field of vaccines.
Collaborations
Some of his notable coworkers include Tal Zaks and Lori Panther, who are also influential figures in the biotechnology sector. Their collaboration fosters an environment of innovation and excellence in vaccine research.
Conclusion
Michael Watson's contributions to mRNA vaccine technology exemplify the importance of innovation in addressing global health challenges. His work continues to pave the way for advancements in vaccine development and public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile